ClinicalTrials.gov
public full text
Public Domain
The IRMI-FMT Trial
Aim of the study is to investigate the effect of Fecal Microbiota Transplantation (FMT) and Checkpoint Inhibitor (CI) re-challenge in prior CI refractory patients on Progression free survival (PFS) and tumor using donor stool of former malignant melanoma patients, who have been in remission due to CI treatment for at least 1 year.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Fecal Microbiome Transplantation in Cirrhosis: Trial in Patients With Decompensated Cirrhosis#864938
- Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure#843762
- A global evaluation of the use of faecal microbiota transplant (FMT)#186553
- Fecal Microbiota Transplantation (FMT) for Clostridium Difficile#879927
- Image 1_Cross-sectional gut microbiota and serum metabolite differences across clinically defined groups in colorectal cancer.tif#353679
Record · ID 882190
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive